SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Modern hypoglycemic therapy requires mandatory self-management of glycemia (SMG). The use of modern glucometers taking into account the human factor in carrying out the SMG will increase the result of hypoglycemic therapy and will be an effective measure in the prevention of the development and progression of diabetic complications.

Full Text

Restricted Access

About the authors

E. V Biryukova

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

Email: lena@obsudim.ru
MD, Prof., Director of Teaching at the Department of Endocrinology and Diabetology Moscow

References

  1. Алгоритмы специализированной медицинской помощи больных сахарным диабетом / Под ред. И.И. Дедова, М.В. Шестаковой, 7-й вып., М., 2015.
  2. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинич. врача 2012;12:32-6.
  3. Baumstark A., Pleus S., Schmidt C., Link M., Haug C., Freckmann G. Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self- Monitoring of Blood Glucose according to !SO 15197. J. Diabetes Sci. Technol. 2012;6(5):1076-86.
  4. Blonde L., Karter A.J. Current evidence regarding the value of self monitored blood glucose testing. Am. J. Med. 2005;118(Suppl. 9A):20-6.
  5. Clar C., Barnard K., Cummins E., Royle P., Waugh N. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol. Assess. 2010;14(12):6.
  6. Nathan D.M., Zinman B., et al., Research Group. Diabetes Control and Complications Trial/ Epidemiology of Diabetes !nterventions and Complications (DCCT/EDIC). Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch. Intern. Med. 2009;169(14);1307-16.
  7. Duckworth W.C., McCarren M., Abraira С. Glucose Control and Cardiovascular Complications: The VA Diabetes Trial. Diabetes Care. 2001;24(5): 942-45.
  8. Farmer A., Wade A., Goyder E. et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:13-8.
  9. Freckmann G., Schmid C., Baumstark A., Pleus S., Link M., Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self- monitoring of blood glucose according to D!N EN !SO 15197. J. Diabetes Sci. Technol. 2012;6(5):1060-75.
  10. Goto A., Arah O.A., Goto M., Terauchi Y., Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013;29(347):f4533.
  11. Graveling A.J., Frier B.M. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 2010;36(Suppl. 3):64-74.
  12. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008;359:1577-89.
  13. Hansen M.V., Pedersen-Bjergaard U., Heller S.R., Wallace T.M., Rasmussen A.K., Jorgensen H.V., Pramming S., Thorsteinsson B. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res. Clin. Pract. 2009;85:183-88.
  14. International Organization for Standardization. !n vitro diagnostic test systems. Requirements for blood-glucose monitoring system for self-testing in managing diabetes mellitus. Reference number !SO 15197:2003 (E). Geneva: !nternational Organization for Standardization. 2003.
  15. Khaled A.A., Sekaran M., IkramS.I. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomedical Research. 2010;21(2):147-50.
  16. Kuo C.Y., Hsu C.T., Ho C.S., et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol. Ther. 2011;13:596-600.
  17. McGeoch G., Derry S., Moore R.A. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab. Res. Rev. 2007;23:423-40.
  18. Neisser K., Weber C., Wenzel H., Schneider B. Costs of self-measurement of blood glucose (SMBG) regarding morbidity and mortality in type 2 diabetes in a reality of care setting (The ROSSO study No 6). The European Association for the Study of Diabetes. Abstract Volume 42st Annual Meeting, Copenhagen, Malmoe. 2006. 141.
  19. O'Kane M.J., Bunting B., Copeland M., et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008;336:1174-77.
  20. ORIGIN Trial Investigators, Gerstein H., Yusuf S., et al. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the OR!G!N Trial (Outcome Reduction with an Initial Glargine Intervention). Am. Heart J. 2008;155(1):26-32.
  21. Polonsky. W.H., Fisher L., Schikman C.H., et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Results from the structured testing program study. Diabetes Care. 2011;34:262-67.
  22. Schmid C., Haug C., Heinemann L., Freckmann G. System Accuracy of Blood Glucose Monitoring Systems: !mpact of Use by Patients and Ambient Conditions. Diabetes Technology & Therapeutics. 2013;15(10):889-96.
  23. Snell-Bergeon J.K., Wadwa R.P Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technology & Therapeutics. 2012;14(Suppl. 1): 51-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies